Pharma Journalist - Page 862 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

BlackThorn receives $8 Million to advance KOR Antagonist Program

NanoSphere Health Sciences Signs Binding Merger Agreement for 100% Acquisition by Corazon Gold Corp.

Navidea Enters Exclusive License and Distribution Agreement For India with Sayre Therapeutics

FDA Accepts Rigel’s New Drug Application for TAVALISSE

Lannett Announces Approval For Amantadine Hydrochloride Capsules USP, 100 mg

Boehringer presents phase III results of adalimumab biosimilar candidate to HUMIRA

Johnson & Johnson Announces Completion of Acquisition of Actelion

Baxter Announces Agreement with Dorizoe Lifesciences to Further Expand Generic Injectables Pipeline

Probiodrug announces encouraging results of the Phase 2a SAPHIR Study

Pfizer Receives Commercialization Rights in Europe for CRESEMBA